TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06664671

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental
Description: Patients will inhale thyme oil via inhaler sticks with instructions on proper usage, supervised by the researcher. Each patient will complete the Patient Introduction Form, Asthma Control Test, and pre-test sections of the Asthma Symptom and Respiratory Parameters Form. Measurements of FEV1 and FEV1/FVC will be recorded. On the fourth day of hospitalization, post-test data will be collected.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients will receive an empty inhaler stick with usage instructions, completing the same pre- and post-test procedures as the intervention group.

Intervention type: OTHER
Group type: OTHER
Intervention: Control (Standard treatment)
Description: Patients will complete pre- and post-test forms without any intervention.
Study: NCT06663553

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: TU-LESS
Description: patients in TU-LESS group will receive transumbilical laparoendoscopic single-site surgery (TU-LESS) for hysterectomy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: vNOTES
Description: patients in vNOTES group will receive transvaginal natural orifice transluminal endoscopic surgery (TU-LESS) for hysterectomy
Study: NCT06663761

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stimuli
Description: Stimuli (the order of stimuli 1-4 will be electronically randomized), with a break time between stimuli of 5-10 minutes:~1. Non-invasive blood pressure measurement~2. Heat~3. Mechanical stimulation~4. Visual stimulation~5. Cold pressor test~6. Spicy taste
Study: NCT04268342

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Resistance guided treatment for gonorrhoea infection
Description: For cases of gonorrhoea infection treated at the return visit, a nucleic acid assay will be used to determine individual eligibility for ciprofloxacin treatment
Study: NCT05166434

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: trans-crestal sinus lifting
Description: this study will be divided in to three different groups, each group will receive a same technique of Crestal maxillary sinus lifting and implant placement at 2,4,6 mm heights.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: trans-crestal sinus lifting
Description: this study will be divided in to three different groups, each group will receive a same technique of Crestal maxillary sinus lifting and implant placement at 2,4,6 mm heights.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: trans-crestal sinus lifting
Description: this study will be divided in to three different groups, each group will receive a same technique of Crestal maxillary sinus lifting and implant placement at 2,4,6 mm heights.
Study: NCT05567991

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Comprehensive Mindulness-Based Intervention (C-MBI)
Description: C-MBI, was administer online via Zoom and included: 10 Integral Meditation classes lasting approximately 35 minutes each, given twice a week (Monday and Wednesday); 10 minutes of yoga exercises focused on breathing and posture before each IM class; and dietary advice. Regarding this latter, the participants received via email a document which entailed non-mandatory dietary suggestions to promote healthy nutrition, sleep and stress-relief. An online lecture held by the nutritionist with a question-and-answer format was also organized. The degree to which to follow this advice was left to the discretion of each participant. The core of our intervention was represented by the IM training, that is a MBI intervention, that simultaneously uses breathing, focusing attention, releasing of physical tensions, thoughts and feeling sensations through internal senses and imagery, allowing a quick relaxation and more deeply a physical, energetic, and spiritual well-being.
Study: NCT05078736

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Moderate intensity intermittent training
Description: In group A participants will receive moderate intensity intermittent training including running of 5 km with 1-min at 70% of maximal aerobic speed with interval of 1-min passive recovery, exercises will be performed by gym trainer for 5 weeks including 3 days/week

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Moderate intensity continuous training
Description: In group B participants will receive moderate intensity continuous training ran continuously the same 5 km at 70% of maximal aerobic speed, exercises will be performed by gym trainer for 5 weeks including 3 days/week.
Study: NCT05495750

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine 0.25% Injectable Solution
Description: ultrasound-guided bilateral suprazygomatic maxillary nerve block using 0.15 ml/kg.
Study: NCT04801524

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-benefit
Description: Participants will be reminded that the vaccine helps protect themselves from COVID.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-benefit
Description: Participants will be reminded that the vaccine helps protect themselves from COVID.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-benefit
Description: Participants will be reminded that the vaccine helps protect themselves from COVID.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prosocial-benefit
Description: Participants will be reminded that the vaccine helps protect their family, friends, and community from COVID

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prosocial-benefit
Description: Participants will be reminded that the vaccine helps protect their family, friends, and community from COVID

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prosocial-benefit
Description: Participants will be reminded that the vaccine helps protect their family, friends, and community from COVID

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Early access
Description: Participants will be reminded that they have early access to COVID-19 vaccine.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Early access
Description: Participants will be reminded that they have early access to COVID-19 vaccine.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fresh start
Description: Participants will be reminded that the vaccine offers the promise of a fresh start and chart a new path forward.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fresh start
Description: Participants will be reminded that the vaccine offers the promise of a fresh start and chart a new path forward.
Study: NCT06392555

Intervention type: DEVICE
Intervention: Device-Aided performances
Description: Determination of the presence of the 8 findings suspicious of CHD by readers, aided by the device

Intervention type: OTHER
Intervention: Device-Unaided performances
Description: Determination of the presence of the 8 findings suspicious of CHD by readers, unaided by the device
Study: NCT05108493

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dry needling
Description: Three sessions dry needling of lateral epicondyle region, once per week with disposable acupuncture needles (0.25x25mm).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home exercise program
Description: All participants will start the home exercise program during the study period consisting of range of motion exercises for wrist flexion, extension, ulnar and radial deviation, elbow flexion and extensor; forearm supinator, and pronator muscles; stretching exercises. Eccentric strengthening of the wrist flexor extensors, ulnar and radial deviation, forearm pronation, supination, and strengthening exercise training will be given to the elbow extensors and flexors. Progressive strengthening exercises will be added to the program. The exercise program will be terminated with stretching exercises. The exercises will be performed for 10 repetitions 2 times a day, stay in each position for 10 seconds, and rest for 30 seconds between periods. Both groups will be advised to continue the exercise program for 12 weeks.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Home exercise program
Description: All participants will start the home exercise program during the study period consisting of range of motion exercises for wrist flexion, extension, ulnar and radial deviation, elbow flexion and extensor; forearm supinator, and pronator muscles; stretching exercises. Eccentric strengthening of the wrist flexor extensors, ulnar and radial deviation, forearm pronation, supination, and strengthening exercise training will be given to the elbow extensors and flexors. Progressive strengthening exercises will be added to the program. The exercise program will be terminated with stretching exercises. The exercises will be performed for 10 repetitions 2 times a day, stay in each position for 10 seconds, and rest for 30 seconds between periods. Both groups will be advised to continue the exercise program for 12 weeks.
Study: NCT04849975

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pelvimetric measurements
Description: The patients in this group are pregnant women after failure of external manual version (EMV) in case of breech fetal presentation. The participants will successively perform MRI pelvimetry (conventional management) and EOS imaging.
Study: NCT06207682

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Avacopan
Description: Orally via capsules

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Avacopan
Description: Orally via capsules

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Simvastatin
Description: Orally via tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Simvastatin
Description: Orally via tablets
Study: NCT05760092

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Institutional standard treatment for xerostomia and Long Covid
Description: (Medical follow-up at the general outpatient clinic for prescription and control of medications, underlying diseases, clinical status and routine short, medium and long-term care follow-up, standard guidelines for the use of aerobic physical activity in those who do not have contraindications, stretching exercises, ergonomics, home adaptation to maximize functionality and energy savings, emotional cognitive support psychotherapy, socio-educational measures, sleep hygiene, Nutritional follow-up and monitoring, dentistry follow-up at the University's odontological team, guidance on proper oral hygiene, use of low-sugar diets, daily topical use of fluoride and antimicrobial mouthwash to prevent dental caries, oral hydration, guidance on avoiding cigarette use or intake of caffeine-containing beverages . When necessary, measures such as oral lubricants, artificial saliva, measures to prevent aspirations, as well as the careful use of liquids during meals, can be instituted ) +

Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: Institutional standard treatment for xerostomia and Long Covid
Description: (Medical follow-up at the general outpatient clinic for prescription and control of medications, underlying diseases, clinical status and routine short, medium and long-term care follow-up, standard guidelines for the use of aerobic physical activity in those who do not have contraindications, stretching exercises, ergonomics, home adaptation to maximize functionality and energy savings, emotional cognitive support psychotherapy, socio-educational measures, sleep hygiene, Nutritional follow-up and monitoring, dentistry follow-up at the University's odontological team, guidance on proper oral hygiene, use of low-sugar diets, daily topical use of fluoride and antimicrobial mouthwash to prevent dental caries, oral hydration, guidance on avoiding cigarette use or intake of caffeine-containing beverages . When necessary, measures such as oral lubricants, artificial saliva, measures to prevent aspirations, as well as the careful use of liquids during meals, can be instituted ) +

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Photobiomodulation Therapy
Description: Application of Red LED in the 3 pairs of major salivary glands (parotid, submandibular and sublingual) extraorally, transcutaneously, for 36 seconds, twice a week for 06 weeks.

Intervention type: RADIATION
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Photobiomodulation Therapy
Description: All parameters as the number of points, dose and place of application of the PBM will be the same as described in the item PBM therapy Intervention Group, however in the placebo PBM equipment will be turned off. The device activation noise will be recorded and used to mimic the irradiation.
Study: NCT04951310

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Philly Vax Sweepstakes
Description: The Philly Vax Sweepstakes is a citywide sweepstakes designed to motivate Philadelphians to get vaccinated against COVID-19. A total of 36 vaccinated Philadelphians will win among three cash prize packages, distributed from the total cash pool. These 36 will be chosen over three drawings, with 12 residents chosen in each drawing.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Philly Vax Sweepstakes
Description: The Philly Vax Sweepstakes is a citywide sweepstakes designed to motivate Philadelphians to get vaccinated against COVID-19. A total of 36 vaccinated Philadelphians will win among three cash prize packages, distributed from the total cash pool. These 36 will be chosen over three drawings, with 12 residents chosen in each drawing.
Study: NCT05990049

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hyadent BG
Description: Hyadent BG is a cross-linked hyaluronic acid. 1,6% cross-linked hyaluronic acid (xHA), 0,2% native hyaluronic acid (HA)
Study: NCT06034080

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Changes to the electronic health record (EHR)
Description: EHR changes will include minor changes to prescription fields to make it easier for clinicians to order wait and see antibiotics to be filled only if the child worsens or does not improve rather than antibiotics to take immediately.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Changes to the electronic health record (EHR)
Description: EHR changes will include minor changes to prescription fields to make it easier for clinicians to order wait and see antibiotics to be filled only if the child worsens or does not improve rather than antibiotics to take immediately.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Individualized audit and feedback reporting for clinicians
Description: Automated audit and feedback reports detailing participating clinicians' antibiotic prescribing habits for AOM both individually and in comparison to their peers will be shared with clinicians on a quarterly basis throughout the intervention period.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Individualized audit and feedback reporting for clinicians
Description: Automated audit and feedback reports detailing participating clinicians' antibiotic prescribing habits for AOM both individually and in comparison to their peers will be shared with clinicians on a quarterly basis throughout the intervention period.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Clinician education sessions
Description: Virtual education sessions will be held for clinicians to learn more about national guidelines for antibiotic prescribing for AOM, etc. The sessions will be recorded and distributed to clinicians who were unable to attend. Attendance of these sessions will apply toward continuing medical education credits for participants.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinician education sessions
Description: Virtual education sessions will be held for clinicians to learn more about national guidelines for antibiotic prescribing for AOM, etc. The sessions will be recorded and distributed to clinicians who were unable to attend. Attendance of these sessions will apply toward continuing medical education credits for participants.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Use of a shared decision-making (SDM) aide
Description: A previously validated SDM aide for AOM will be used by clinicians during visits with children with AOM. The aide will be available online and in paper form.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Shared decision-making (SDM) education
Description: Clinicians will receive education on SDM and how to use the aid via virtual, recorded sessions.
Study: NCT05069662

Intervention type: OTHER
Intervention: Directive Interview
Description: One directive interview conducted by telephone
Study: NCT05222568

Intervention type: BEHAVIORAL
Intervention: Lateral positioning
Description: After the DLT intubation, the patient is placed in lateral decubitus position

Intervention type: BEHAVIORAL
Intervention: Lateral positioning
Description: After the DLT intubation, the patient is placed in lateral decubitus position
Study: NCT04856917

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imsidolimab
Description: Humanized Monoclonal Antibody
Study: NCT05222568

Intervention type: DEVICE
Intervention: Cuff pressure measurement
Description: The pressure of the bronchial cuff should be measured with cuff-manometer in supine position, and then measurement should be repeated after lateral positioning

Intervention type: DEVICE
Intervention: Cuff pressure measurement
Description: The pressure of the bronchial cuff should be measured with cuff-manometer in supine position, and then measurement should be repeated after lateral positioning
Study: NCT05080582

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mother-Scented Simulated Hand
Description: Preterm neonates wrapped with a warm Mother-Scented Simulated Hand during the invasive procedures

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: NICU Standard Care
Description: Neonates were placed in a side-lying position, while their extremities were flexed close to the body and wrapped with rolled sheets or towels to simulate the intrauterine posture.
Study: NCT03051451

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: combination metformin hydrochloride/ fluoxetine 500/20 mg
Description: Group A will receive metformin 1000 mg and 40 mg of fluoxetine; after the increment phase.~All treatment groups will receive, in addition to the intervention, recommendations of a diet based on a hyper protein, hypo caloric and low carbohydrate diet as well as an exercise routine according to age and physical condition
Study: NCT04866134

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ERAS-007
Description: ERAS-007 will be administered orally as specified in Arm description.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ERAS-007
Description: ERAS-007 will be administered orally as specified in Arm description.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ERAS-007
Description: ERAS-007 will be administered orally as specified in Arm description.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ERAS-007
Description: ERAS-007 will be administered orally as specified in Arm description.
Study: NCT04856917

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imsidolimab
Description: Humanized Monoclonal Antibody

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT04866134

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ERAS-601
Description: ERAS-601 will be administered orally as specified in Arm description.
Study: NCT05070624

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The Virtual Peer Support Program
Description: Training: We have previously developed and beta-tested a virtual peer mentor training program adapted from the St. Jude's Research Hospital's (Memphis, USA) program for FCs of children with cancer for adults using HMV. Content \& Design of the Virtual Peer-Support Program: The program will be delivered by the aTouchAway™ App used for the LIVE program. Participants will be requested to access peer mentors ≥1 time/week. Participants can choose to interact with a peer mentor which will be assigned as well as other peer participants. Onboarding: Participants and mentors will create a personal profile of their caregiving situation (e.g., duration of care, family member age and diagnosis), to enable selection of mentors by the research team believed to be well suited to address support needs, questions, and concerns based on similar lived experience.
Study: NCT03945500

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Investigational Mobile Medical Software Application & IT Dashboard Application, FDA approved Bluetooth spirometer, FDA approved pulse oximeter
Description: Standardized Home Spirometry (SHS) Method consists of an Investigational Mobile Medical Application embedded into an Android Tablet, an FDA approved Bluetooth spirometer, an FDA approved pulse oximeter. HIPAA compliant data will be sent to an Investigational IT dashboard maintained at the Central Monitoring Institute Server.~Volunteers will train in-center or remotely \& perform baseline testing with the SHS method along with a baseline laboratory-based spirometry test (if practicable).~Pre-Surveillance Phase: Daily home spirometry method testing for 4 to 10 weeks to enable normal range calibration.~Surveillance Phase: At least weekly home spirometry method testing for 2-10 months of participation. Volunteers will maintain a test log during study team directed SHS software pathway functionality testing.
Study: NCT05107310

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pedicle screws insertion by free hand technique
Description: Spinal deformity correction. Pedicle screws are inserted using free hand technique with the help of intraoperative fluoroscopy if needed.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pedicle screws insertion by free hand technique
Description: Spinal deformity correction. Pedicle screws are inserted using free hand technique with the help of intraoperative fluoroscopy if needed.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pedicle screws insertion using ARSN
Description: Spinal deformity correction. Pedicle screws are inserted using augmented reality surgical navigation (ARSN) with the ClarifEye navigation system and the Philips Allura 2D/3D imaging system.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pedicle screws insertion using IRSN
Description: Spinal deformity correction. Pedicle screws are inserted using infra-red surgical navigation (IRSN) with the Brainlab Curve 1.2 navigation system combined with the Medtronic O-arm 2D/3D imaging system.
Study: NCT05362032

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo transrectal MRI-targeted biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endorectal Magnetic Resonance Imaging
Description: Endorectal MRI